455
Participants
Start Date
March 11, 2011
Primary Completion Date
March 1, 2013
Study Completion Date
August 29, 2017
pomalidomide
4 mg pomalidomide capsules administered orally
Dexamethasone
40 mg dexamethasone (or 20 mg for participants \> 75 years of age) tablets administered orally
Hopitaux Universitaires de Geneve-HUG, Geneva
Royal Prince Alfred Hospital, Camperdown
Wollongong Hospital, Wollongong
UZ Leuven, Leuven
Peter MacCallum Cancer Institute, East Melbourne
Alfred hospital, Melbourne
Frankston Hospital, Frankston
Border Medical Oncology, Wodonga
Royal Adelaide Hospital, Adelaide
Odense Universitetshospital, Odense C
Sir Charles Gairdner Hospital, Nedlands
Vejle Hospital, Vejle
UniversitatSspital Zurich, Zurich
UZ Gent, Ghent
Hæmatologisk afd. B Aalborg Sygehus Syd, Aalborg
AOU San Luigi Gonzaga, Orbassano
Azienda Ospedaliera San Giovanni Battista, Torino
Alexandra General Hospital of Athens, Athens
Institut Paoli-Calmettes, Marseille
Clinica Ematologica- A.O.U. San Martino, Genova
Hospital Donostia, San Sebastián (Guipuzcoa)
Askepios Klinik St. Georg, Hamburg
Hospital de La Princesa, Madrid
Hospital 12 de Octubre, Madrid
Hospital Clinic, Placenza
Hopital Purpan, Tulouse Cedex 9
CHRU - Hopital du Haut Leveque, Pessac
Universita degli Studi di Padova, Padua
Hospital Universitario de Salamanca, Salamanca
Hopital Bretonneau, Tours
Hospital Universitario Marques de Valdecilla, Santander
Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi, Bologna
Servizio di Ematologia, A.O. - Arcispedale S.Maria Nuova, Reggio Emilia
CHRU Nantes, Nantes
Universitatsklinikum Essen, Essen
Hospital de la Fe, Valencia
CHU d'Angers, Angers
CHU Nancy, Vandœuvre-lès-Nancy
Mayo Clinic, Rochester
CHRU de Lille FR, Lille
Centre Hospitalier de la cote basque, Bayonne
Universitatsklinikum Heidelberg, Heidelberg
Centre Hospitalier Lyon Sud, Pierre-Bénite
University of Tubingen, Tübingen
Overlakare Medocomcentrum, hematologi, Uppsala
Hopital Saint-Louis, Paris
CHU Hôpital St-Antoine, Paris
Oncoematologia, Istituto Nazionale Tumori Fondazione G. Pascale, Napoli
Centre Hospitalier Departemental, La Roche-sur-Yon
Universitatsklinikum Ulm, Ulm
Universitatsklinikum Wurzburg, Würzburg
State Institution Hematological Research, Centre of Russian Academy of Medical Science, Moscow
State Institution Moscow Regional Research Clinical Institute, Moscow
St. Petersburg Research Institute of Hematology and Blood Transfusion, Saint Petersburg
State Educational Institution, Saint Petersburg State Medical University, Saint Petersburg
Princess Alexandra Hospital, Brisbane
Calvary Mater Hospital, Waratah
CHU UCL Mont-Godinne-Dinant asbl, Yvoir
Tom Baker Cancer Center, Calgary
Cross Cancer Institute, Edmonton
British Columbia Cancer Agency, Vancouver
James Cancer Hospital, Halifax
Juravinski Cancer Centre, Hamilton
London Health Sciences Centre, London
University Health Network, Toronto
Maisonneuve Rosemont, Montreal
Royal Victoria Hospital McGill Department of Oncology(RVH), Montreal
Sir Mortimer B. Davis - Jewish Genl, Montreal
Charles University General Hospital, Prague
Aarhus University Hospital, Arhus C
Universitatsklinikum Carl Gustav Carus, Dresden
Universitatsklinikum Jena, Jena
Universitatsklinikum Leipzig, Leipzig
Univerita La Sapienza Dipartimento di Biotecnologie Cellulari ed Ematologia, Rome
VU University Medical Center, Amsterdam
Erasmus Medical Center, Rotterdam
University Medical Center Utrecht, Utrecht
Hospital Universitari Germans Trias i Pujol, Badalona (Barcelona)
Hospital Clinic Provincial de Barcelona, Barcelona
Department of Hematology Hematology Centre, Gothenburg
University Hospital in Lund, Lund
Karolinska University Hospital Huddinge, Stockholm
Karolinska University Hospital, Stockholm
Medizinische Universitatsklinik, Bern
Royal Bournemouth Hospital, Bournemouth
St James's University Hospital, Leeds
St.Bartholomew's Hospital, London
King's College Hospital, London
Freeman Hospital, Newcastle upon Tyne
Nottingham City Hospital, Nottingham
Derriford Hospital, Plymouth
Royal Hallamshire HospitalSheffield Teaching Hospitals NHS Trust, Sheffield
The Royal Marsden Hospital, Sutton-Surrey
The Royal Wolverhampton Hospital NHS Trust, Wolverhampton
Lead Sponsor
Celgene
INDUSTRY